This medication is a reversible non-competitive inhibitor of acetylcholinestrace, prescribed for mild to moderate dementia in patients with Alzheimer's or Parkinson's disease. It prevents the breakdown of a chemical called acetylcholine.
The starting dose (rivastigmine tartrate) is 1.5 mg twice a day (BID).
It comes as a capsule to take by mouth, with or without food.
• Caution should be exercised in patients with history of kidney problems, certain heart problems, seizures, stomach or bowel problems, lung or breathing problems, urinary blockage, any allergy, who are taking other medications, during pregnancy and breastfeeding.
• It may cause dizziness, drowsiness, or fainting, do not drive a car or operate machinery while taking this medication.
Nausea, vomiting, diarrhoea, dyspepsia, anorexia, headache, drowsiness, weight loss, asthenia. Agitation, confusion, depression, sweating. Gastrointestinal haemorrhage. Potential for baldder outflow obstruction.
Avoid excess dosage.
Store it at room temperature and in an airtight container.
Subscribe to our Free Newsletters!